Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2010
Phase I trial of combination chemotherapy with docetaxel, cisplatin and S-1 (TPS) in patients with locally advanced or recurrent/metastatic head and neck cancerM Tahara, K Araki, S Okano, et al.
Cancer Chemotherapy and Pharmacology|September 3, 2010
Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancerD Takahari, T Hamaguchi, K Yoshimura, et al.
British Journal of Cancer|May 24, 2012
KRAS mutations in primary tumours and post-FOLFOX metastatic lesions in cases of colorectal cancerY Kawamoto, K Tsuchihara, T Yoshino, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
An open-label phase Ib/II study of trastuzumab deruxtecan combined with nivolumab and CAPOX for HER2-low gastroesophageal adenocarcinomaY Aoki, I Nakayama, Y Komura, et al.
Cancer Chemotherapy and Pharmacology|December 17, 2010
Phase 1 study of conatumumab, a pro-apoptotic death receptor 5 agonist antibody, in Japanese patients with advanced solid tumorsT Doi, H Murakami, A Ohtsu, et al.
British Journal of Cancer|September 19, 2013
Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancerW Koizumi, K Yamaguchi, H Hosaka, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Cancer registry as external control data for regulatory submission in JapanH Bando, N Okita, Y Sakamoto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2014
Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancerY Yamada, K Higuchi, K Nishikawa, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
VOLTAGE-2: multicenter phase II study of nivolumab monotherapy in patients with mismatch repair-deficient resectable locally advanced rectal cancerH Bando, Y Tsukada, S Kumagai, et al.
ESMO Open|October 10, 2025
A multicenter phase II study of eribulin for BRAF V600E mutant metastatic colorectal cancer: the BRAVERY study (EPOC1701)T Masuishi, H Taniguchi, D Kotani, et al.
Pageof 4